Discover millions of ebooks, audiobooks, and so much more with a free trial

Only $11.99/month after trial. Cancel anytime.

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 3
Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 3
Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 3
Ebook875 pages10 hours

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 3

Rating: 0 out of 5 stars

()

Read preview

About this ebook

Frontiers in Clinical Drug Research - Anti-Cancer Agents is an eBook series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology researchers.

The third volume of the eBook series begins with a detailed review of the molecular biology of inhibitors that target EGF-family receptors. This review is divided into two parts that covers extracellular and intracellular molecules. Other reviews cover targeted therapies for cancers such as melanoma, follicular lymphoma and topics such as cancer immunotherapy, apoptosis targeting and the Warburg Effect.
LanguageEnglish
Release dateMay 31, 2016
ISBN9781681082899
Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 3
Author

Atta-ur Rahman

Atta-ur-Rahman, Professor Emeritus, International Center for Chemical and Biological Sciences (H. E. J. Research Institute of Chemistry and Dr. Panjwani Center for Molecular Medicine and Drug Research), University of Karachi, Pakistan, was the Pakistan Federal Minister for Science and Technology (2000-2002), Federal Minister of Education (2002), and Chairman of the Higher Education Commission with the status of a Federal Minister from 2002-2008. He is a Fellow of the Royal Society of London (FRS) and an UNESCO Science Laureate. He is a leading scientist with more than 1283 publications in several fields of organic chemistry.

Read more from Atta Ur Rahman

Related to Frontiers in Clinical Drug Research - Anti-Cancer Agents

Related ebooks

Chemistry For You

View More

Related articles

Reviews for Frontiers in Clinical Drug Research - Anti-Cancer Agents

Rating: 0 out of 5 stars
0 ratings

0 ratings0 reviews

What did you think?

Tap to rate

Review must be at least 10 words

    Book preview

    Frontiers in Clinical Drug Research - Anti-Cancer Agents - Atta-ur Rahman

     ebook_preview_excerpt.html}r#GޫhH0ͦ8fwQ@*.dC} ׎}yy[f*[v8a@Uɓwo.ޞ_D߽|nD:-S5$*諸,%OuUy"΢7en*:Fgy/2:[%y] >gVSG|%USeZ4,4)m"۲뤊U|-}xHJ|@a+ Z޿2'zogb.r,zuQN]\G) _Wq.`Ie[ \[HbfO/58 mUB+\Mh1$ː*Ouǰh Y,KU2!-sOȫ*bg5 )y^w3|6]GSRa*BX&9eIMbZCI;EESVH3*%W#x2MU%Q.EMjSE2EV85-4KWH3RZ ѻM퐂DؾhQU51's/C"l(mdBϫbqUe:O*~SS359m-U\. Ii\7^5sG N 7L޹952OVru 3#@&Kb:ly{4G +wBmC+AW9eo$>!6 DP%s 'ev :{3xzV(7MSB+3`<ۏ7?itn8By@ A$.*F=inl %Q4y+RvSdp@WvZkHxy-d&FЃ xR`R{ER QFwDz1(ܲX0>û$QRcw&ٱH #bBbsKK}:X=;e# }UE6ELy<8}F[![xaJlYE+\5.n}bE3^obe`ހJ~fnoNޏ]'߁ߞҨw)|}~G`V WQ> [{:6$8料AU9mO9ȯ<ހ>\?~ӏرq^9$:$u (]|{fDaH&S6Qf|%.ޚc Ln[ޒ3#ibP,}]D΋R:mtdh*] ~`ᇟE~DܽH{ކ':/`&% (x ܏|9HB s-e{ ZN\F).IhJ| fFA8fY1RIO9=p|'bٮww4>F݀}n'54A!"{?6·@A!;ON$[ /Op2/D2|c AXI/O?ِ{dBY,ډ&CþhrYQw]c[Q,+ /7PPVU5]XS{Ff[{;6ʳ!x=/y<hu@ni5]-; ZTSͿ`rDZIJ5D(` l|$^?8wa+u9)L_ގÛEP,A)gy±%ErETS 9-ZHm D?mU$I?ŕi L^IX^nZXa=I 2Qz|Q\ waDGw!9y4<0# B IIRʙ9JP& bQzȈ{1,gJEITfV1jXk/qN V"H/p:C+oS{ ]a糃Ћ)rox7P[w}{B]p!0zS0P&uZUA ?!;hXn Z.QO @1LĸdƔt3Q ]ܢeCjCh[-S3D ^/CtmJԯ~ ND\ H7 >5&\lN OuZUV/2IG l{~ UmI(.]?ohA%s=xT~7˯mӁ cCIWF' vWZB%cD2a04&ǫ? g3؀7N!zUJu 5]I䃲]7B6|ۆ>%Zha8~WxW[3#-sdT $*q2GS 8f,$ QHOJ@4|V%J~%6r(ʒ=huJ2/l(=uaR-@~0Kך1mzPgtJ"ЃAtwo}\\ /szk-~^[wOy1"$JWIP }`҉L]]xu}p 9E5jLb+LV6qe2jn8)qi)!/Ĝ7mCVMn\br`acH}!ޢb/[7U+ŹŶX9(0u!5[ %%Y] "C FMBrǎN^IⰬd1ɭ(}>w|z|@4>o|zxf!=Ќ*nn(yGG#e¡tt5gޝy22 VFObVfbK &(7,HfÏmw| > yY@Q0,a;\E1GyY&-kɂnZ,ʤv*gRT11e$W=9dӢs3tz^|e5+rL 0@l$4sn̋EFV7bllV,jQ+2l!'M?c۹nla{w[#!IΓ! |)̖8(QS[ c/uceblO?+K_J9& zi|&CcRцt_ W٠[Q%lٰMN+ % s-C&,STkU%#BQ8t/Bldr(ʹy.J@8"I ~zs+7aLNTi;~)9 7K3 C/5 x \OO)d?eTt\%xlEpyp'^ EkBpT (̴ ICwho A-*2jHAX[7`?<+?_Ϩ. *)Dyt\$kBi?Ͻaz7+ķ{4-#XȈ,bXWj:.Wtx2&)yV %9߿93DT: 0*c {"ŬOLY&(ULRkX }K!bhnQKr >rl #UsyqE$EY(=̔P]杖Kk b,֍`Be`JqJȇ0>'@"ro%^/ |0}sHP D[6^.P/ r1JP.tH_Ąn(B4 5B`~9d.SdLAt4{";Njw)Eօ 0KszWG`=12@!o+W@VegqQqi 3 b ?dEǰ#R ^IQGx]@wT X;4K-ۧB ԢD)2œ>z>Z%5.s gȄ s&sȷiS G.YsFM=mB%mYX1L:70^2` PRKwHJxzTГ:X@pQޔ+87/ J&*{7(IA3g>bܞv?kDHPNgy 14xx2v4cy(M{3D"F:p 7_l21M YnAPb FJ bfkOB"`."O =1bADg| >@<%8+|兮oOu!GG5Xc2 ˰Q"[7rayKOGJXZtvyq}wݝ\^y7_g QzȆwDok9 ȋ,ɝsq[ϰ2KђYXJ_8{V5 `4ƂQtK&Y&7 FeX$K=!2YBɗQ1NH#%̔ bhZ$ OгPP+O*?9vеvb-p-OSdUQB5WBU 3 s@N> Q<75s[pnTOIXJr]$O$==bXttV8 < %8=cXNr0sImAܚʤ?3^ EZU>A;W0^eH0T ՘6>nD6hɲ)h0@b) RR 1|$q AD vIH~2>!"XpmMܽdIP R6Dի(+Xw. \$yrB*&K& jM !3(u(&l|$3t=W.3f/:AG4 У99W~:VGخ$L>W\Yx1OJ_VB@(Է53+ ߈PSzua/|%sM\>`džU*幗t7~ ~V OV n/JqGLߤYB`#~[ӉkH`^CZBe=5dR&Gʙ?on]Ĉ$1vt>|tK9UlۗM9F}U2 W)f;1U<=TDIQkj)gFmr=Q3>iMz%3ɵD6R[ sQ|LT fyՊ,oP]J\[‹ 4Hifgȸ ំ/^ Ľ8FMB挶$w8?\s uƮ9t4x&`mi|2} Mc jɁiNIå$b xX,E F~#=TyMýs&\ba&.}ے-~<#:)lPڣcT"] I>?cqپcԤ"ۓ=sf6L|F/8Ud/í|5/8EFhC ՅkdJ=k0HJ ԺNBjglɞbtͯN7JQ%Z\)F_6yr =ƯS.QO'Dt+#B>ej3yc3^[m1y@.(7erUmCČ!A]M 0S0LQ{::&M,X4MUE (nW۷kIqstb7;(ã% zv ".Pb2]RNF/#V(j1 F!/%P^D`~)lz[%1G;,#m˔YRѐk`X&@dEAF Y!V] .2/WU|SSn /sqG4?:ԁjR!sD?E1rFL:y0m"Y[@ :AeA":Ri;cOVȚdZ-Ip<iZxo 3gpl_qg vlǮbݹ9gqbzLIenn:ق$Jl?kObx+:Rl3j&./ F<0S/P;$12izjdc\u y/boIyҾ ;Q4n/M 1Cx2d^!L=,pkf\E9-ǑFeJ5\Ex &Db2.!lՑ'+nDĀ=-ֆO8_r&\fNX e,= IbxS#+;gL4H.g0ƣhL7p+$ V.wp1,%xHW' : kGՁ+lrxJEzYm/ȼ0_pSK [~Kq"x|Ϸ}j2 YvW}+r[̣kI+Vzܳ0˗`x (S.Dq``DǩkByYQfg86P?.٬֦)jew)ZrWZ,APZ#84Yin<ݸ^GpFxΨw qj&~>v?'㙄>J@; n+0n=(ճpyxF\ܚ/Tӌ##0RGǫ&_  \6{fe[=@ Ǻҽ쟽iy &&ZL_<02tT0F JA|(ED%`u'7Aű3OP7؏eeܙ۝_-3a q4l@x._0.-{ɝQ/V('LZg8Ju.n/-^hP4W؂b<)% [:0-'{~䥿{W|8a(| ׏gѮ62E׮vm| RuT//}ҕ1~lk~ etS&wmӥTLmԛ{B~6M4yxJ~< ~HþH-#QƠlR۰arn۽gz?~[/,=gU}zI}xu!.5J+`+oN ^+5ꪯBU؅WNGQCܸwt./T8|oK/*@j;xlt4ͷ^0H}b3ŌzUnnw՞1=ǧepӷ_FNVܷJNgc[ Q`D-Mû}6ܓ9~/0 yo{*CFInZq9jtؽTΌ'}cA>.1haD0-28,u7UZ%*p;g$&X'snb4f<5>IAT^<<.>cI Q)/or8ʠ/CT┶0 xr#40&|AR{KKx2qJ jGWrPB8T^ة&*L9r< JwAs]rIchRdY`w"tdTcAzjeSϤ:4+%`HCj9vT7͸ڣϨ^Kq.t) 3W&Jgݨ q4ޑh S.f bQ8;3Cq -T(7XLU\M@I.`<Ά|ƇF?J#ƑoLI3nLtiSW\D `cSLsyKK490p7$]=dF; 4a  \ i&[ =!]VaɂD3cRs{l;;B*8HPkZ&֑:,k JyǕ4LΌyHpmLNx6$ :r-d >),dcik.>M\cOZE1z!SFT#SuS>ʺVM"o7LtbV3NEMjrv͏7Ǜ7W竻Dgo۫;}]vm4]]Goo]37x׷K a{6"&#K{a%J*vşLFtbnEY$S +7jK@8ʍy$!eqKn^ۖyZ~--HM+tq mvnRжJfL1/$]o[ȂY4)ir] e`i6 !֓Xv0!]~j[&fK#)WDvwchID՞.\1e"If'YLwt5xX2sDahtɚΌ]>6E*=YLYa}$nVEJFCpF5;،3-Yש:vQ`}Iw16e!Gq,`bDlicP>ln`h&Øno5Dh w^$<_M㠗 wsk{EQ.uV^aQ"|Lxes#<\S!E#0;, *fI4oQOmѩ+8ubu2c$$R\V{]Pabɻ5ǫi8R&t ?!tzI\tX7v>,4LľԞ1NJ^NG]qkV|?P*|ijB7[^ۢE}~7|D`C\Ea[r3܎h>UBuZ墑!{v 9$=OL2ٛK^䱟`nZ)K@^ s |"Cl)Ɇ.C0HL𨮨uf+JÞ1n%hp}?@dY{?@" 3P.lƘN'dU:ݾz6;:Lɰ62ӐysOPAEhU1ِaӋw$? al6*p37kDAߚ<wAājxYȆGW!^ 4FɎxl-&Qr*2>4i13(Lig^[M\ )mGGwALnӴE41ź̠ۢX^@Q$bq=-ブS1}(XðUCL -lG9"~ ǙGQB h?N=*rE ԭ3U58(*e)fSPtw~txuJݴݵ)](fi:쒚+B5pOl̯V!׼ISh%p&nY>̍kPw{a $eK]W_-c}/-}##d^*4_u1C٬l6%o21!s 8їCT_>,@^H[=cTG)w0 wn|:z=Ueɾ MGn3JrI@AGGTB:|]W7SDk;B/F3;( z9xEm5 1dgX;53U⬰yRTkBVВ-Z<`0s}f35>ln׋y}.7fa{2Ew/:95ږ}?Blc2r´P h!HJE9c"@{nmr&֕oEͣ$}"0ˢs38ɞvIIծ >*u~2emQx*(Vd63 w.dt8$ރ\bWس2 _0 P?ih.tTaI.T: vBsdHP~& wϋsEi(CGÏt YW-e5&hM| le691iTvLll&n=@ƃ ^D[jΒ)V͔-Rs6-$^"cZJfqmXXR[;pi'T<[VgTSV{3'{`K N%GS ltGۏ:jpxW]#>N晄Mpe$yzX\m7h"IrF)Tte´460&HJ;LrEO21+Kr' (s(*պa4􇉬q 9׸]3wȊ<-?˶8 ʧh>'PBw8+&ŝ(@ ܳ ߥDW34:cs]鲊 P&$e؜:[In ҎLURaI'b[{|2L@ܗ#\ImyYfnB|vZǔ>SXľWAE;m4\ c8-^vSrzح++63Ge@#=k h%k]H21Iͦ~G%|7ES(gaPCp}7fGj6I/^lj:m-"mڿ-'4KŠ[aۈ Nf\96zGd4؇Oq,kt7Gz;6,laacYH7B|%{d {ODߜ ߿ΎNTax@<VMuHHRNypC_z4"]hq*Pv D.CT-*pT9S?9^Rpd@.v-߇`;_eR=~2/O76T6ŨL+ru\3vV%kG4L1Li-utf*kaZ3;ei1oФ2|-cQu e ЦSA7Ihe\n[le@)Hğnrjx3cPU>'ހ q{i,M>U"@pxW J* [qNym%FHUVXoj$HZPκ .6 M1u겯|׉V\A&n'/`rhRM{RlZ,i:V,d4=ъ-w6éVǹGprȸB \6!f$λbж?NQ`PŮmѷ=> ۺIThv򪕰/9EvCI3?x)y~kJ8~c)w_nщx+ƣSάo;(b?on=tX)9n8I^x5Ajpip{A "jo~F,uyU{h a7dyOw\"?)tQ#祒ʖR%sn887u-CT)pl>Vѡ^8-)H\+iU֞/b Rua_,+aa*E?a:~zT/KV$= CcP X&-$  x-|+0oTKP٤o{k I
    Enjoying the preview?
    Page 1 of 1